Namilumab

Generic Name
Namilumab
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
1206681-39-1
Unique Ingredient Identifier
MED485W763
Background

Namilumab has been used in trials studying the treatment of Plaque Psoriasis and Rheumatoid Arthritis.

Associated Conditions
-
Associated Therapies
-
medpagetoday.com
·

UnitedHealthcare CEO Killed; Mystery Illness Kills 143; RFK Jr.'s Fluoride Water Biz

Brian Thompson, CEO of UnitedHealthcare, was fatally shot in Manhattan. An unknown disease killed 143 in the DRC. Misinformation is predicted to worsen in healthcare. Over 3 million could lose Medicaid coverage. Raw milk production suspended due to bird flu. GWU Hospital residents voted to strike for better pay and mental health benefits. Dual vapers and smokers less likely to quit. Nursing home industry seeks reversal of CMS's staffing mandate. Upcoding linked to high-intensity hospital stays. RFK Jr. opposes fluoridated water but once sold it. Anemia prevalence in the U.S. was 9.3%. Idaho's abortion trafficking law upheld. Non-governmental Dept. of Govt. Efficiency may end daylight saving time. E. coli outbreak in McDonald's Quarter Pounders resolved. Patients seek state help to avoid medical debt. Colorado doctor educates on medical aid in dying. DEA nominee Chad Chronister withdraws. FDA and USDA seek clarity on food labeling dates. Roivant discontinues namilumab development. Elton John suffers eye infection affecting vision. AMA opposes 'nurse anesthesiologist' title.
firstwordpharma.com
·

Kinevant's namilumab fails to deliver in pulmonary sarcoidosis

The article discusses the importance of enabling JavaScript for optimal app performance.
biospace.com
·

Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of ...

Namilumab failed to show treatment benefit in pulmonary sarcoidosis patients; Kinevant Sciences to discontinue further development of namilumab for sarcoidosis treatment.
© Copyright 2024. All Rights Reserved by MedPath